ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALTH

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2011/03/03	07:04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:29	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/26	07:26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/17	23:00	Business Wire	Allos Therapeutics to Report Fourth Quarter and Full Year 2010 Results on March 3, 2011	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/15	06:40	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/15	05:08	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/11	04:37	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/10	20:02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/02/10	20:02	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/01/20	08:31	Business Wire	Journal of Clinical Oncology Publishes Results from Pivotal Phase 2 PROPEL Study of FOLOTYN® in Relapsed or Refractory Perip...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/01/11	22:04	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/01/11	22:00	Business Wire	Allos Therapeutics Reports 2010 Financial Highlights and 2011 Key Business Priorities	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2011/01/05	06:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/22	06:36	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/21	22:00	Business Wire	Allos Therapeutics’ Marketing Authorisation Application (MAA) for FOLOTYN® Accepted for Review by European Medicines Agenc...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/20	22:00	Business Wire	Allos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/11	05:15	Business Wire	New Analysis from Phase 2b Study Reinforces Favorable Survival Data Observed with FOLOTYN® Relative to Erlotinib in Advanced...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/05	23:00	Business Wire	Updated Results from FOLOTYN® Phase 1 Dose Finding Study Demonstrates Activity in Relapsed or Refractory Cutaneous T-Cell Ly...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/04	23:00	Business Wire	New Analysis from FOLOTYN® PROPEL Trial Demonstrates Activity in Relapsed or Refractory Transformed Mycosis Fungoides	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/04	23:00	Business Wire	Allos Therapeutics Reports New Analyses of FOLOTYN® Data from PROPEL trial in Relapsed or Refractory Peripheral T-Cell Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/12/01	22:00	Business Wire	Allos Therapeutics Announces FOLOTYN® Data to Be Presented as a Late Breaker at the 2010 Chicago Multidisciplinary Symposium...	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/11/19	22:00	Business Wire	New FOLOTYN® Data to Be Presented at the 2010 American Society of Hematology Annual Meeting	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/11/05	05:10	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/11/05	05:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/11/05	05:00	Business Wire	Allos Therapeutics Reports Third Quarter 2010 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
2010/10/27	05:00	Business Wire	Allos Therapeutics to Report Third Quarter 2010 Financial Results on November 4, 2010	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)